Clinical Trial: Clinical efficacy study protocol for the application of high-dose rhBMP-2-loaded self-curing calcium phosphate artificial bone (granular) in translateral anterior lumbar interbody fusion (OLIF). (China)

Posted On: 2026-08-12

China, Aug. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Clinical efficacy study protocol for the application of high-dose rhBMP-2-loaded self-curing calcium phosphate artificial bone (granular) in translateral anterior lumbar interbody fusion (OLIF).'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600129844

Registration Time: 2026/08/11

Type: Interventional study

Primary Sponsor: West China Hospital, Sichuan University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=321142

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Clinical efficacy study protocol for the application of high-dose rhBMP-2-loaded self-curing calcium phosphate artificial bone (granular) in translateral anterior lumbar interbody fusion (OLIF). (China)